Almost 120,000 anonymized data records have already been identified for patients with hematologic malignancies. Research is now being focused on finding the most effective therapies that can cover the entire research spectrum for these forms of cancer, bringing new hope for those suffering from the less common types
GMV is the technological partner responsible for the secure platform that stores the data and makes it available for scientific analysis, with anonymization of the data and harmonization based on the common OMOP data model